financetom
Business
financetom
/
Business
/
Adtech platform MNTN targets up to $1.24 billion valuation in US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Adtech platform MNTN targets up to $1.24 billion valuation in US IPO
May 26, 2025 7:54 AM

May 14 (Reuters) - MNTN, an advertising platform for

internet-connected TVs with Ryan Reynolds as its chief creative

officer, said on Wednesday it is targeting a $1.24 billion

valuation in its U.S. initial public offering.

The company, along with some investors, plans to raise up to

$187.2 million through a sale of 11.7 million shares priced

between $14 and $16 each.

Progress in trade negotiations between the White House and

other countries has boosted equities in recent weeks, offering

IPO candidates a window to list their shares after tariffs had

disrupted their plans.

Retail trading platform eToro started trading on the Nasdaq

on Wednesday. Digital banking firm Chime is also heading towards

a hotly anticipated listing after filing for its IPO on Tuesday.

As cord-cutting accelerates and demand for streaming booms,

more brands are looking to shift their marketing focus on to

connected TVs, boosting companies such as MNTN that can aid the

transition.

Austin, Texas-based MNTN was backed by BlackRock ( BLK ) and

Fidelity Management and Research in a 2022 funding round.

BlackRock ( BLK ) has also indicated an interest in purchasing up to $30

million worth of shares in the IPO, MNTN said.

The company aims to trade on the New York Stock Exchange

under the symbol "MNTN". Morgan Stanley, Citigroup and Evercore

are among the underwriters for the IPO.

(Reporting by Niket Nishant in Bengaluru; Editing by Anil

D'Silva and Krishna Chandra Eluri)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta Platforms Insider Sold Shares Worth $22,705,057, According to a Recent SEC Filing
Meta Platforms Insider Sold Shares Worth $22,705,057, According to a Recent SEC Filing
Dec 17, 2024
03:34 AM EST, 12/17/2024 (MT Newswires) -- Mark Zuckerberg, 10% Owner, Director, Chair of Board and Chief Executive Officer, on December 12, 2024, sold 35,921 shares in Meta Platforms ( META ) for $22,705,057. Following the Form 4 filing with the SEC, Zuckerberg has control over a total of 555,204 shares of the company, with 555,204 controlled indirectly. SEC Filing:...
Analysis-Vietnam's sweeping administrative cuts stir investors' anticipation, worries
Analysis-Vietnam's sweeping administrative cuts stir investors' anticipation, worries
Dec 17, 2024
HANOI (Reuters) - Communist-run Vietnam is planning its boldest bureaucratic reform in decades, slashing ministries, agencies and broadcasters in a bid to reduce bottlenecks and red tape, but risking short-term paralysis, officials and investors said. Under the plan, five ministries, four government agencies and five state TV channels would be among the bodies that will cease to exist, according to...
Robinhood Markets Insider Sold Shares Worth $1,803,982, According to a Recent SEC Filing
Robinhood Markets Insider Sold Shares Worth $1,803,982, According to a Recent SEC Filing
Dec 17, 2024
03:32 AM EST, 12/17/2024 (MT Newswires) -- Baiju Bhatt, Director, on December 12, 2024, sold 45,077 shares in Robinhood Markets ( HOOD ) for $1,803,982. Following the Form 4 filing with the SEC, Bhatt has control over a total of 2,521 shares of the company, with 2,521 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1783879/000178387924000335/xslF345X05/wk-form4_1734391910.xml ...
EUDA Health in Joint Venture Discussions With Guangdong Cell Biotech
EUDA Health in Joint Venture Discussions With Guangdong Cell Biotech
Dec 17, 2024
03:33 AM EST, 12/17/2024 (MT Newswires) -- EUDA Health Holdings ( EUDA ) said late Monday it has entered into preliminary discussions with Guangdong Cell Biotech to form a joint venture. The potential collaboration between EUDA and Guangdong, a stem cell-focused biotech company, is aimed at biotechnology and consumer health sector innovations, the company said. The two companies have not...
Copyright 2023-2026 - www.financetom.com All Rights Reserved